A raw and honest look at one woman's decades-long struggle with pain and undiagnosed fibromyalgia, and the breakthrough ...

[6] The authors stated that two-month treatment with trazodone ... statistically significant effect on fibromyalgia severity, depression, anxiety and pain interference with daily activities ...

Though researchers still don’t know what causes the disorder, studies show that people with fibromyalgia have an increased ...

The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

The following is a summary of “Feasibility of attention-based virtual reality interventions in fibromyalgia syndrome: comparing systems, virtual environments and activities,” published in the January ...

Not only is pain common in bipolar disorder, but greater negative affect (negative emotional states like sadness, anger, or despair) is also common in fibromyalgia. Fibromyalgia treatment focuses ...

22, 2023 — There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia ... for Chronic Pain on the Rise ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

The patent, when formally approved, will reinforce protection for Silo’s lead asset, SPC-15, an intranasal treatment targeting post-traumatic stress disorder (PTSD). The patent includes newly added ...

TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA ...